This content was prepared by Milford Asset Management and is being published by NZME as advertorial.

Episode 27: The rise and fall of Ryman – what’s next?

Ryman Healthcare has been in the news recently, raising $1bn of new equity – it’s second raise in two years. Pre-Covid, the company was a top performing stock, so what went wrong, and what’s ahead? Milford Portfolio Manager Sam Trethewey talks to Ryan Bridge about Ryman’s turnaround.

Click here to watch, read, listen: milfordasset.com/insights/ep27-the-rise-and-fall-of-ryman-whats-next

Want more investment insights? Check out Milford’s The Investing Place for exclusive masterclass content, news and opinion pieces.

To learn more about investing with Milford visit here

Disclaimer: This content is intended to provide you with general information only. It does not take into account your objectives, financial situation or needs. Milford Funds Limited is the issuer of the Milford KiwiSaver Plan and Milford Investment Funds. Please read the relevant Milford Product Disclosure Statement at milfordasset.com. Before investing you may wish to seek financial advice. For more information about Milford’s financial advice services, visit milfordasset.com/getting-advice. Financial Advice Disclosure Statements for all Milford Financial Advisers are available on request free of charge. Past performance is not a reliable indicator of future performance.